Platelet-Rich Plasma (PRP) versus High-Volume Image-Guided Injections (HVIGI) for Achilles Tendinopathy

In the management of chronic, recalcitrant Achilles tendinopathy that has plateaued despite dedicated exercise loading, injection therapies are frequently contemplated. Among biological and mechanical injection options, Platelet-Rich Plasma (PRP) and High-Volume Image-Guided Injections (HVIGI) represent two prominent yet fundamentally distinct modalities. Platelet-rich plasma involves centrifuging autologous venous blood to concentrate platelets containing growth factors such as platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta), which are theoretically injected into tendon substance to accelerate cellular healing. Conversely, High-Volume Image-Guided Injections utilize large volumes of normal saline combined with local anesthetic and a small anti-inflammatory agent injected under real-time ultrasound directly into the peritendinous interface between the deep Achilles tendon and Kager's fat pad. Rather than targeting cellular repair, HVIGI works through mechanical hydro-dissection to obliterate pain-generating neovascular ingrowth and associated nerve sprouts.

Marketing Hype across Indian Private Clinics and Patient Expectations

Across private corporate hospitals and orthopaedic clinics in tier-1 Indian metros like Mumbai, Delhi, Bengaluru, and Chennai, PRP injections are heavily marketed as cutting-edge biological cures for sports injuries. Patients dealing with long-standing morning heel stiffness and pain after standing on hard kitchen tiles or walking barefoot are frequently offered expensive multi-dose PRP packages costing tens of thousands of rupees per injection. Often, patients are led to believe that a single biological injection will immediately resolve years of tendon dysrepair without requiring rigorous exercise. In contrast, High-Volume Image-Guided Injections are less widely advertised despite having substantially stronger mechanistic evidence for neovascular mechanical disruption. Many patients spend substantial financial resources on PRP only to find their symptoms unaltered, underscoring the critical need for unbiased clinical education regarding true therapeutic efficacy and the non-negotiable role of active physiotherapy.

Biological Signaling Limitations versus Mechanical Hydro-Dissection Mechanics

The scientific rationale underpinning PRP relies on local growth factor degranulation stimulating tenocyte proliferation and extracellular matrix synthesis. However, rigorous double-blind, sham-controlled randomized clinical trials (such as the landmark de Vos study published in JAMA) have repeatedly demonstrated that intratendinous PRP yields no statistically significant clinical superiority over plain saline injections or structured eccentric exercise alone. Intratendinous needle fenestration itself carries risks of localized structural microtrauma. In stark contrast, HVIGI achieves its therapeutic effect through mechanical hydro-dissection. Under high-resolution musculoskeletal ultrasound visualization, thirty to fifty millilitres of sterile saline solution are infused into the interface separating the ventral Achilles tendon from Kager's fat pad. The high fluid pressure mechanically shears and collapses the fragile, disorganized neovascular capillary complexes and destroys the accompanying unmyelinated sensory nerve fibers that transmit chronic nociceptive signals, providing immediate mechanical denervation and creating a favorable local environment for collagen remodeling.

Post-Injection Progressive Loading Windows and Kinetic Chain Restoration

Neither PRP nor HVIGI functions as a standalone cure; both modalities merely serve as biological or mechanical facilitators to create a transient window of pain relief. Following an injection, the tendon must be systematically loaded to guide tissue remodeling. After HVIGI, patients observe forty-eight to seventy-two hours of relative mechanical rest in supportive footwear, strictly avoiding barefoot walking on hard floors or sudden stretching. On day four post-injection, structured progressive loading begins with isometric soleus and gastrocnemius holds on flat surfaces, advancing over subsequent weeks into heavy slow resistance training and dynamic eccentric heel drops. If active mechanical loading is omitted following injection, the mechanical benefits of neovascular stripping gradually dissipate, and pain inevitably recurs as abnormal neural ingrowth re-establishes within six to twelve months, leaving the patient with persistent disability and recurrent tendon pain during everyday weight-bearing walking, leaving the patient unable to resume regular athletic pursuits or climb stairs comfortably.

Frequently Asked Questions